China Universal Asset Management Co., Ltd. Annexon, Inc. Transaction History

China Universal Asset Management Co., Ltd.

$893 Million
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 21, 2024	BUY	$2.13 - $3.84 $1,433 - $2,584	673 Added 96.83%	1,368 $3,000
Q3 2023 Oct 30, 2023	BUY	$2.13 - $3.84 $1,433 - $2,584	673 Added 96.83%	1,368 $3,000
Q2 2023 May 21, 2024	BUY	$2.1 - $6.37 $102 - $312	49 Added 7.59%	695 $2,000
Q2 2023 Jul 27, 2023	BUY	$2.1 - $6.37 $102 - $312	49 Added 7.59%	695 $2,000
Q1 2023 May 21, 2024	BUY	$3.74 - $7.46 $605 - $1,208	162 Added 33.47%	646 $2,000
Q1 2023 Apr 27, 2023	BUY	$3.74 - $7.46 $605 - $1,208	162 Added 33.47%	646 $2,000
Q4 2022 May 21, 2024	BUY	$4.56 - $6.61 $2,207 - $3,199	484 New	484 $2,000
Q4 2022 Jan 31, 2023	BUY	$4.56 - $6.61 $173 - $251	38 Added 8.52%	484 $3,000
Q3 2022 Oct 21, 2022	BUY	$3.75 - $6.63 $1,672 - $2,956	446 New	446 $3,000

Others Institutions Holding ANNX

# of Institutions

158

Shares Held

102M

Call Options Held

3.61M

Put Options Held

1.08M

Bain Capital Life Sciences Investors, LLC Boston, MA

8.45M
Shares

$55.3 Million
8.98% of portfolio
Satter Management Co., L.P.

7.41M
Shares

$48.5 Million
76.44% of portfolio
Bvf Inc San Francisco, CA

7M
Shares

$45.9 Million
1.05% of portfolio
Black Rock Inc. New York, NY

6.59M
Shares

$43.1 Million
0.0% of portfolio
Redmile Group, LLC San Francisco, CA

6.43M
Shares

$42.1 Million
2.05% of portfolio

View Full List

About Annexon, Inc.

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $312M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

More about ANNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account